EIA
PFE icon

Eastover Investment Advisors’s Pfizer PFE Stock Holding History

Eastover Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-126,578
Closed -$4.64M – 47
2023
Q2 		$4.64M Buy
126,578
+1,243
+1% +$48.4K 2.48% 25
2023
Q1 		$5.11M Buy
125,335
+3,436
+3% +$148K 2.86% 22
2022
Q4 		$6.25M Buy
121,899
+881
+0.7% +$42.2K 3.58% 11
2022
Q3 		$5.12M Buy
121,018
+644
+0.5% +$31.3K 3.19% 14
2022
Q2 		$6.31M Buy
120,374
+2,543
+2% +$130K 3.85% 6
2022
Q1 		$6.1M Buy
117,831
+13,244
+13% +$687K 3.22% 8
2021
Q4 		$6.18M Buy
104,587
+1,881
+2% +$93.2K 3.57% 7
2021
Q3 		$4.42M Buy
102,706
+1,848
+2% +$81.9K 2.88% 20
2021
Q2 		$3.95M Buy
100,858
+5,198
+5% +$202K 2.57% 23
2021
Q1 		$3.47M Sell
95,660
-6,837
-7% -$243K 2.45% 26
2020
Q4 		$3.77M Sell
102,497
-6,143
-6% -$225K 2.61% 22
2020
Q3 		$3.78M Buy
108,640
+2,110
+2% +$74K 2.87% 19
2020
Q2 		$3.31M Buy
106,530
+4,514
+4% +$153K 2.73% 22
2020
Q1 		$3.16M Buy
+102,016
New +$3.48M 3.07% 16

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eastover Investment Advisors's PFE Position: Q3 2023 in Review

Eastover Investment Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 126,578 shares — an estimated $4.64M sold.

Eastover Investment Advisors first reported a position in PFE in Q1 2020 and held it in 14 quarters. The position peaked at $6.31M in Q2 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Eastover Investment Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Eastover Investment Advisors sold 126,578 Pfizer shares in Q3 2023, an estimated $4.64M.
  • Eastover Investment Advisors first reported a position in Pfizer in Q1 2020 and held it in 14 quarters.
  • Eastover Investment Advisors's Pfizer position peaked at $6.31M in Q2 2022.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Eastover Investment Advisors's 13F filing for Q3 2023, filed 16 Oct 2023.